Ra Capital Management, L.P. - Director, 10%+ Owner at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
JANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Ra Capital Management, L.P. - trading volume in the past year for Janux Therapeutics, Inc.

Holdings reported by Ra Capital Management, L.P. for Janux Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.25K $160K $25.56 Jun 11, 2025 Indirect
Stock Option (Right to Buy) 11.7K Jun 11, 2025 Indirect Common Stock

Transactions reported by Ra Capital Management, L.P. for Janux Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.